A 68-year-old man with COPD (FEV₁ 35% predicted) presents with a 3-day history of cough, purulent sputum, and dyspnea. He was hospitalized 2 weeks ago for an acute exacerbation and discharged on oral corticosteroids. On examination: temperature 38.5°C, respiratory rate 28/min, SpO₂ 88% on room air. Chest X-ray shows a new infiltrate in the right lower lobe. Blood cultures are pending. Sputum Gram stain shows gram-negative rods. Which organism is most likely responsible, and what is the most appropriate empiric antibiotic regimen?

Explanation

## Clinical Context: Risk Factors for Pseudomonas in CAP This patient has multiple risk factors for Pseudomonas aeruginosa infection: - Severe COPD (FEV₁ < 50%) - Recent hospitalization (within 2 weeks) - Recent corticosteroid use (immunosuppression) - Gram-negative rods on sputum Gram stain **Key Point:** Pseudomonas aeruginosa is a gram-negative rod that causes CAP in patients with structural lung disease (COPD, bronchiectasis, cystic fibrosis) and those with recent healthcare exposure or immunosuppression. ## Diagnostic Clues | Feature | Significance | |---------|-------------| | Gram-negative rods on sputum | Rules out S. pneumoniae (gram-positive cocci) and H. influenzae (small gram-negative coccobacillus) | | Recent hospitalization | Increases risk of resistant gram-negative organisms | | Severe COPD (FEV₁ 35%) | Pseudomonas risk factor; structural lung damage | | Corticosteroid use | Impairs neutrophil function and cellular immunity | ## Empiric Antibiotic Strategy **High-Yield:** In CAP with risk factors for Pseudomonas, use: - **Piperacillin-tazobactam** (4.5 g IV Q6H) — preferred beta-lactam/beta-lactamase inhibitor - **Fluoroquinolone** (levofloxacin 750 mg IV/PO daily or ciprofloxacin 400 mg IV Q8H) — alternative monotherapy - Consider adding **aminoglycoside** (gentamicin or tobramycin) if severe or septic **Clinical Pearl:** Pseudomonas requires anti-pseudomonal agents; standard CAP antibiotics (amoxicillin, ceftriaxone, azithromycin) are inadequate and will lead to clinical failure and resistance selection. ## Why Not the Others? - **S. pneumoniae** produces gram-positive diplococci, not gram-negative rods - **H. influenzae** is a small gram-negative coccobacillus (not typical rod morphology) and is covered by ceftriaxone, but the clinical context (recent hospitalization, severe COPD) points to Pseudomonas - **M. pneumoniae** is an atypical organism (no cell wall, not visible on Gram stain) and does not present with purulent sputum or gram-negative rods [cite:Harrison 21e Ch 297]